Kaplonek, Paulina
Cizmeci, Deniz http://orcid.org/0000-0003-3231-7726
Kwatra, Gaurav
Izu, Alane
Lee, Jessica Shih-Lu
Bertera, Harry L. http://orcid.org/0000-0001-7431-6436
Fischinger, Stephanie http://orcid.org/0000-0003-2307-3379
Mann, Colin http://orcid.org/0000-0003-0949-2075
Amanat, Fatima
Wang, Wenjun
Koen, Anthonet L.
Fairlie, Lee
Cutland, Clare L. http://orcid.org/0000-0001-8250-8307
Ahmed, Khatija
Dheda, Keertan http://orcid.org/0000-0001-7709-5341
Barnabas, Shaun L.
Bhorat, Qasim Ebrahim
Briner, Carmen
Krammer, Florian http://orcid.org/0000-0003-4121-776X
Saphire, Erica Ollman http://orcid.org/0000-0002-1206-7451
Gilbert, Sarah C. http://orcid.org/0000-0002-6823-9750
Lambe, Teresa
Pollard, Andrew J. http://orcid.org/0000-0001-7361-719X
Nunes, Marta
Wuhrer, Manfred http://orcid.org/0000-0002-0814-4995
Lauffenburger, Douglas A.
Madhi, Shabir A. http://orcid.org/0000-0002-7629-0636
Alter, Galit http://orcid.org/0000-0002-7680-9215
Article History
Received: 9 May 2022
Accepted: 12 April 2023
First Online: 15 June 2023
Competing interests
: G.A. is a founder/equity holder in Seromyx Systems Inc. and Leyden Labs. She has served as a scientific advisor for Sanofi Vaccines and has collaborative agreements with GSK, Merck, Abbvie, Sanofi, Medicago, BioNtech, Moderna, BMS, Novavax, SK Bioscience, Gilead and Sanaria. The remaining authors declare no conflicting interests.